Report Detail
Global Extended-release Medication Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4531947 |
- 23 May, 2023 |
- Global |
- 103 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Extended-release Medication market size was valued at USD 36250 million in 2022 and is forecast to a readjusted size of USD 55620 million by 2029 with a CAGR of 6.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Extended-release Medication market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Extended-release Medication market size and forecasts, in consumption value ($ Million), 2018-2029
Global Extended-release Medication market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Extended-release Medication market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Extended-release Medication market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Extended-release Medication
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Extended-release Medication market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Novartis, Bayer, Johnson & Johnson and Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Extended-release Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Original Medication
Generic Medication
Market segment by Application
Hospital
Drugstore
Other
Market segment by players, this report covers
Sanofi
Novartis
Bayer
Johnson & Johnson
Takeda
AstraZeneca
AbbVie
Pfizer
Collegium Pharmaceutical, Inc
Endo Pharmaceuticals
Shanghai Shyndec Pharmaceutical
Zhuhai Rundu Pharmaceutical
China Res Double-Crane
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Extended-release Medication product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Extended-release Medication, with revenue, gross margin and global market share of Extended-release Medication from 2018 to 2023.
Chapter 3, the Extended-release Medication competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Extended-release Medication market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Extended-release Medication.
Chapter 13, to describe Extended-release Medication research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Extended-release Medication
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Extended-release Medication by Type
- 1.3.1 Overview: Global Extended-release Medication Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Extended-release Medication Consumption Value Market Share by Type in 2022
- 1.3.3 Original Medication
- 1.3.4 Generic Medication
- 1.4 Global Extended-release Medication Market by Application
- 1.4.1 Overview: Global Extended-release Medication Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Drugstore
- 1.4.4 Other
- 1.5 Global Extended-release Medication Market Size & Forecast
- 1.6 Global Extended-release Medication Market Size and Forecast by Region
- 1.6.1 Global Extended-release Medication Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Extended-release Medication Market Size by Region, (2018-2029)
- 1.6.3 North America Extended-release Medication Market Size and Prospect (2018-2029)
- 1.6.4 Europe Extended-release Medication Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Extended-release Medication Market Size and Prospect (2018-2029)
- 1.6.6 South America Extended-release Medication Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Extended-release Medication Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Sanofi
- 2.1.1 Sanofi Details
- 2.1.2 Sanofi Major Business
- 2.1.3 Sanofi Extended-release Medication Product and Solutions
- 2.1.4 Sanofi Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Sanofi Recent Developments and Future Plans
- 2.2 Novartis
- 2.2.1 Novartis Details
- 2.2.2 Novartis Major Business
- 2.2.3 Novartis Extended-release Medication Product and Solutions
- 2.2.4 Novartis Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Novartis Recent Developments and Future Plans
- 2.3 Bayer
- 2.3.1 Bayer Details
- 2.3.2 Bayer Major Business
- 2.3.3 Bayer Extended-release Medication Product and Solutions
- 2.3.4 Bayer Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Bayer Recent Developments and Future Plans
- 2.4 Johnson & Johnson
- 2.4.1 Johnson & Johnson Details
- 2.4.2 Johnson & Johnson Major Business
- 2.4.3 Johnson & Johnson Extended-release Medication Product and Solutions
- 2.4.4 Johnson & Johnson Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Johnson & Johnson Recent Developments and Future Plans
- 2.5 Takeda
- 2.5.1 Takeda Details
- 2.5.2 Takeda Major Business
- 2.5.3 Takeda Extended-release Medication Product and Solutions
- 2.5.4 Takeda Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Takeda Recent Developments and Future Plans
- 2.6 AstraZeneca
- 2.6.1 AstraZeneca Details
- 2.6.2 AstraZeneca Major Business
- 2.6.3 AstraZeneca Extended-release Medication Product and Solutions
- 2.6.4 AstraZeneca Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 AstraZeneca Recent Developments and Future Plans
- 2.7 AbbVie
- 2.7.1 AbbVie Details
- 2.7.2 AbbVie Major Business
- 2.7.3 AbbVie Extended-release Medication Product and Solutions
- 2.7.4 AbbVie Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 AbbVie Recent Developments and Future Plans
- 2.8 Pfizer
- 2.8.1 Pfizer Details
- 2.8.2 Pfizer Major Business
- 2.8.3 Pfizer Extended-release Medication Product and Solutions
- 2.8.4 Pfizer Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Pfizer Recent Developments and Future Plans
- 2.9 Collegium Pharmaceutical, Inc
- 2.9.1 Collegium Pharmaceutical, Inc Details
- 2.9.2 Collegium Pharmaceutical, Inc Major Business
- 2.9.3 Collegium Pharmaceutical, Inc Extended-release Medication Product and Solutions
- 2.9.4 Collegium Pharmaceutical, Inc Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Collegium Pharmaceutical, Inc Recent Developments and Future Plans
- 2.10 Endo Pharmaceuticals
- 2.10.1 Endo Pharmaceuticals Details
- 2.10.2 Endo Pharmaceuticals Major Business
- 2.10.3 Endo Pharmaceuticals Extended-release Medication Product and Solutions
- 2.10.4 Endo Pharmaceuticals Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Endo Pharmaceuticals Recent Developments and Future Plans
- 2.11 Shanghai Shyndec Pharmaceutical
- 2.11.1 Shanghai Shyndec Pharmaceutical Details
- 2.11.2 Shanghai Shyndec Pharmaceutical Major Business
- 2.11.3 Shanghai Shyndec Pharmaceutical Extended-release Medication Product and Solutions
- 2.11.4 Shanghai Shyndec Pharmaceutical Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Shanghai Shyndec Pharmaceutical Recent Developments and Future Plans
- 2.12 Zhuhai Rundu Pharmaceutical
- 2.12.1 Zhuhai Rundu Pharmaceutical Details
- 2.12.2 Zhuhai Rundu Pharmaceutical Major Business
- 2.12.3 Zhuhai Rundu Pharmaceutical Extended-release Medication Product and Solutions
- 2.12.4 Zhuhai Rundu Pharmaceutical Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Zhuhai Rundu Pharmaceutical Recent Developments and Future Plans
- 2.13 China Res Double-Crane
- 2.13.1 China Res Double-Crane Details
- 2.13.2 China Res Double-Crane Major Business
- 2.13.3 China Res Double-Crane Extended-release Medication Product and Solutions
- 2.13.4 China Res Double-Crane Extended-release Medication Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 China Res Double-Crane Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Extended-release Medication Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Extended-release Medication by Company Revenue
- 3.2.2 Top 3 Extended-release Medication Players Market Share in 2022
- 3.2.3 Top 6 Extended-release Medication Players Market Share in 2022
- 3.3 Extended-release Medication Market: Overall Company Footprint Analysis
- 3.3.1 Extended-release Medication Market: Region Footprint
- 3.3.2 Extended-release Medication Market: Company Product Type Footprint
- 3.3.3 Extended-release Medication Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Extended-release Medication Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Extended-release Medication Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Extended-release Medication Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Extended-release Medication Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Extended-release Medication Consumption Value by Type (2018-2029)
- 6.2 North America Extended-release Medication Consumption Value by Application (2018-2029)
- 6.3 North America Extended-release Medication Market Size by Country
- 6.3.1 North America Extended-release Medication Consumption Value by Country (2018-2029)
- 6.3.2 United States Extended-release Medication Market Size and Forecast (2018-2029)
- 6.3.3 Canada Extended-release Medication Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Extended-release Medication Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Extended-release Medication Consumption Value by Type (2018-2029)
- 7.2 Europe Extended-release Medication Consumption Value by Application (2018-2029)
- 7.3 Europe Extended-release Medication Market Size by Country
- 7.3.1 Europe Extended-release Medication Consumption Value by Country (2018-2029)
- 7.3.2 Germany Extended-release Medication Market Size and Forecast (2018-2029)
- 7.3.3 France Extended-release Medication Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Extended-release Medication Market Size and Forecast (2018-2029)
- 7.3.5 Russia Extended-release Medication Market Size and Forecast (2018-2029)
- 7.3.6 Italy Extended-release Medication Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Extended-release Medication Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Extended-release Medication Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Extended-release Medication Market Size by Region
- 8.3.1 Asia-Pacific Extended-release Medication Consumption Value by Region (2018-2029)
- 8.3.2 China Extended-release Medication Market Size and Forecast (2018-2029)
- 8.3.3 Japan Extended-release Medication Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Extended-release Medication Market Size and Forecast (2018-2029)
- 8.3.5 India Extended-release Medication Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Extended-release Medication Market Size and Forecast (2018-2029)
- 8.3.7 Australia Extended-release Medication Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Extended-release Medication Consumption Value by Type (2018-2029)
- 9.2 South America Extended-release Medication Consumption Value by Application (2018-2029)
- 9.3 South America Extended-release Medication Market Size by Country
- 9.3.1 South America Extended-release Medication Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Extended-release Medication Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Extended-release Medication Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Extended-release Medication Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Extended-release Medication Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Extended-release Medication Market Size by Country
- 10.3.1 Middle East & Africa Extended-release Medication Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Extended-release Medication Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Extended-release Medication Market Size and Forecast (2018-2029)
- 10.3.4 UAE Extended-release Medication Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Extended-release Medication Market Drivers
- 11.2 Extended-release Medication Market Restraints
- 11.3 Extended-release Medication Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Extended-release Medication Industry Chain
- 12.2 Extended-release Medication Upstream Analysis
- 12.3 Extended-release Medication Midstream Analysis
- 12.4 Extended-release Medication Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Extended-release Medication. Industry analysis & Market Report on Extended-release Medication is a syndicated market report, published as Global Extended-release Medication Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Extended-release Medication market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
